The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?

Best Value Stocks to Buy for September 10th

06:16am, Wednesday, 10'th Sep 2025
CZFS, SRCE and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 10, 2025.

New Strong Buy Stocks for September 2nd

06:51am, Tuesday, 02'nd Sep 2025
RSI, UDMY, NVST, DORM and CFBK have been added to the Zacks Rank #1 (Strong Buy) List on September 2, 2025.
Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors target stocks that have been on a bullish run. Stocks like POST, MD, NVST and ZION are seeing price strength, and the momentum is likely to continue.
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their
The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.
Stocks like FHI, NVST, COMM and FLS are seeing price strength and have a high chance of carrying the momentum forward.
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Four GARP picks with low PEG ratios and strong growth potential include Kontoor Brands, Envista, Western Digital and LATAM Airlines.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck

Envista Q2 Revenue Jumps 7.7%

02:22pm, Tuesday, 05'th Aug 2025
Envista Q2 Revenue Jumps 7.7%
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE